Subscribe to RSS
DOI: 10.1055/s-2006-956499
A Concise Formal Synthesis of Unnatural (+)-Aphanorphine from (2S,4R)-4-Hydroxyproline
Publication History
Publication Date:
20 December 2006 (online)
Abstract
(-)-Aphanorphine methyl ether was synthesized in ten steps from commercially available (2S,4R)-4-hydroxyproline, featuring the C-2 configuration inversion of an intermediate amide and intramolecular Friedel-Crafts reaction. The present work constitutes a formal synthesis of unnatural (+)-aphanorphine.
Key words
aphanorphine - configuration inversion - intramolecular Friedel-Crafts - marine alkaloid - synthesis
- 1
Gulavita N.Hori A.Shimizu Y.Laszlo P.Clardy J. Tetrahedron Lett. 1988, 29: 4381 -
2a
Takano S.Inomata K.Sato T.Ogasawara K. J. Chem. Soc., Chem. Commun. 1989, 1591 -
2b
Takano S.Inomata K.Sato T.Takahashi M.Ogasawara K. J. Chem. Soc., Chem. Commun. 1990, 290 -
2c
Honda T.Yamamoto A.Cui YS.Tsubuki M. J. Chem. Soc., Perkin Trans. 1 1992, 531 -
2d
Hume AN.Henry SS.Meyers AI. J. Org. Chem. 1995, 60: 1265 -
2e
Meyers AI.Schmidt W.Santiago B. Heterocycles 1995, 40: 525 -
2f
Fadel A.Arzel P. Tetrahedron: Asymmetry 1995, 6: 893 -
2g
Hallinan KO.Honda T. Tetrahedron 1995, 51: 12211 -
2h
Node M.Imazato H.Kurosaki R.Kawano Y.Inoue T.Nishide K. Heterocycles 1996, 42: 811 -
2i
Shiotani S.Okada H.Nakamata K.Yamamoto T.Sekino F. Heterocycles 1996, 43: 1031 -
2j
Fadel A.Arzel P. Tetrahedron: Asymmetry 1997, 8: 283 -
2k
Fadel A.Arzel P. Tetrahedron: Asymmetry 1997, 8: 371 -
2l
Shimizu M.Kamikubo T.Ogasawara K. Heterocycles 1997, 46: 21 -
2m
Tamura O.Yangimachi T.Kobayashi T.Ishibashi H. Org. Lett. 2001, 3: 2427 -
2n
Fuchs JR.Funk RL. Org. Lett. 2001, 3: 3923 -
2o
Tanaka K.Taniguchi T.Ogasawara K. Tetrahedron Lett. 2001, 42: 1049 -
2p
El Azab AS.Taniguchi T.Ogasawara K. Heterocycles 2002, 56: 39 -
2q
Kita Y.Futamura J.Ohba Y.Sawama Y.Ganesh JK.Fujioka H. J. Org. Chem. 2003, 68: 5917 -
2r
Zhai H.Luo S.Ye C.Ma Y. J. Org. Chem. 2003, 68: 8268 -
2s
Hu H.Zhai H. Synlett 2003, 2129 -
2t
Taylor SK.Ivanovic M.Simons LJ.Davis MM. Tetrahedron: Asymmetry 2003, 14: 743 -
2u
Tamura O.Yanagimachi T.Ishibashi H. Tetrahedron: Asymmetry 2003, 14: 3033 -
2v
Katoh M.Inoue H.Suzuki A.Honda T. Synlett 2005, 2820 -
2w
Bower JF.Szeto P.Gallagher T. Chem. Commun. 2005, 5793 - 3
Shiotani S.Kometani T.Mitsuhashi K.Nozawa T.Kurobe A.Fitsukaichi O. J. Med. Chem. 1976, 19: 803 - 4
Palmer DC.Strauss MJ. Chem. Rev. 1977, 77: 1 -
5a
Coppola GM.Schuster HF. Asymmetric Synthesis-Construction of Chiral Molecules Using Amino Acids John Wiley & Sons; New York: 1987. -
5b
Hanessian S. Total Synthesis of Natural Products: The ‘Chiron’ Approach Pergamon; Oxford: 1983. -
5c
Ho T.-L. Enantioselective Synthesis: Natural Products from Chiral Terpenes John Wiley & Sons; New York: 1992. -
6a
Croce PD.Rosa CL. Tetrahedron: Asymmetry 2002, 13: 197 -
6b
Portoghese PS.Turcotte JG. Tetrahedron 1971, 27: 961 - 7
Williams JM.Jobson RB.Yasuda N.Marchesini G.Dolling U.-H.Grabowski EJJ. Tetrahedron Lett. 1995, 36: 5461 - 9
Huffman JW.Yu S. Bioorg. Med. Chem. 1998, 6: 2281 - 10
Mäkelä T.Matikainen J.Wähälä K.Hase T. Tetrahedron 2000, 56: 1873 - 11
Barton DHR.Bielska MT.Cardoso JM.Cussans NJ.Ley SV. J. Chem. Soc., Perkin Trans. 1 1981, 1840 - 13
Albaugh PA.Marshall L.Gregory J.White G.Hutchison A.Ross PC.Gallagher DW.Tallman JF.Crago M.Cassella JV. J. Med. Chem. 2002, 45: 5043
References and Notes
8: colorless solid; mp 70-72 °C; [α]26 D +95.7 (c = 0.91, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.70-2.20 (m, 2 H), 2.55-3.05 (m, 1.5 H), 3.08-3.24 (m, 1.5 H), 3.50-3.60 (m, 1 H), 3.78 (s, 3 H), 4.00-4.30 (m, 1 H), 4.40-4.60 (m, 1 H), 6.55-6.70 (m, 1 H), 6.87 (d, J = 8.1 Hz, 1.5 H), 7.20 (d, J = 7.8 Hz, 1.5 H), 7.35-7.50 (m, 5 H). 13C NMR (75 MHz CDCl3): δ = 37.0, 37.8, 55.1, 57.0, 57.6, 69.2, 113.6, 126.2, 127.1, 128.1, 130.1, 130.6, 136.4, 158.0, 170.0. MS (ESI): m/z = 312 (100) [M + H], 333 (73) [M + Na - H], 366 (15) [M + MeOH + Na], 645 (21) [2 × M + Na]. HRMS (EI): m/z calcd for C19H21NO3: 311.1521; found: 311.1518.
1211: colorless oil; [α]28 D +76.2 (c = 1.53, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.48 (s, 2 H), 1.59 (s, 1 H), 1.90-2.10 (m, 2 H), 2.81 (s, 0.67 H), 2.98 (dd, J = 2.4, 17.1 Hz, 0.67 H), 3.30-3.54 (m, 2.66 H), 3.76 (s, 2 H), 3.80 (s, 1 H), 4.32-4.37 (m, 0.33 H), 4.85-4.91 (m, 0.67 H), 6.70-6.80 (m, 1.65 H), 6.86 (d, J = 2.4 Hz, 0.35 H), 6.97 (d, J = 8.4 Hz, 0.35 H), 7.07 (d, J = 8.4 Hz, 0.65 H), 7.30-7.37 (m, 3.25 H), 7.41-7.48 (m, 1.75 H). 13C NMR (75 MHz, CDCl3): δ = 20.6, 20.8, 34.8, 37.3, 40.0, 41.0, 41.9, 42.2, 54.7, 54.9, 55.0, 56.4, 61.5, 64.1, 109.4, 109.5, 111.4, 111.5, 124.0, 125.3, 126.1, 126.5, 127.8, 128.1, 129.1, 129.2, 129.9, 130.2, 136.7, 137.2, 144.7, 145.6, 157.5, 157.9, 168.7, 169.8. MS (ESI): m/z = 308 (100) [M + H], 330 (6) [M + Na], 362 (19) [M + MeOH + Na]. HRMS (EI): m/z calcd for C20H21NO2: 307.1572; found: 307.1570.
14(-)-Aphanorphine methyl ether 12: colorless oil; [α]28 D -10.38 (c = 1.36, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.46 (s, 3 H, CH3), 1.83 (d, J = 11.1 Hz, 1 H, 0.5 × CH2), 2.01 (dd, J = 6.0, 11.1 Hz, 1 H, 0.5 × CH2), 2.46 (s, 3 H, NCH3), 2.74 (d, J = 6.0 Hz, 1 H, 0.5 × CH2), 2.81 (s, 1 H, 0.5 × CH2), 2.84 (s, 1 H, 0.5 × CH2), 3.02 (d, J = 16.8 Hz, 1 H, 0.5 × CH2), 3.37-3.40 (m, 1 H, NCH), 3.75 (s, 3 H, OCH3), 6.67 (dd, J = 2.1, 8.4 Hz, 1 H, CH), 6.77 (s, 1 H, CH), 7.00 (d, J = 8.4 Hz, 1 H, CH). 13C NMR (75 MHz, CDCl3): δ = 21.2, 35.3, 41.3, 41.4, 42.9, 54.9, 61.1, 71.0, 109.1, 110.8, 125.6, 129.9, 147.6, 157.5. MS (EI): m/z = 218 (18) [M + H], 217 (48) [M], 202 (100), 159 (64), 144 (28), 115 (38). HRMS (EI): m/z calcd for C14H19NO: 217.1467; found: 217.1460.